Free Emergency Medicine CME 2017‑2018 |


The Best of Stroke Forum 2016  Free Stroke CME
Posted by...Bernard Sklar, MD. 
Free CME Credit Hours...0.5.
CME Credits Awarded by...Vindico Medical Education.
Cost for Credit...Free.
Instruction Type...Video Lectures.
Target Audience...Emergency medicine physicians, neurologists, emergency medicine residents, nurses, physician assistants, nurse practitioners, and other health care professionals involved in the treatment of patients with AIS.
Educational material last updated...November 10, 2016.
CME Credit Expires...November 9, 2017.
Financial Support...Genentech, Inc.
The Best of Stroke Forum 2016 consists of two brief lectures:
• Eligibility for IV Thrombolysis: A Review of Inclusion and Exclusion Criteria
• Stroke Therapy: Examining New Evidence
After competing The Best of Stroke Forum 2016, you should be better able to:
• Apply evidence-based criteria to the selection of candidates for thrombolytic therapy in AIS.
• Evaluate FDA labeling, current data, and clinical practice guidelines on the use of tissue plasminogen activator in the extended 3-hour to 4.5-hour post-onset window.
• Assess recent studies and guidelines on endovascular procedures for AIS.
• Determine the criteria for the concomitant or preferential use of tissue plasminogen activator in patients with AIS who are being considered for endovascular procedures.
• Incorporate shared decision making with patients and their families to improve education and assist in reducing delays in treatment and complications.

The New Insulins are Coming: What Does This Mean to the Practicing Clinician?Free Diabetes CME
Live online June 14, 2016 (Sessions 1 and 2) and August 4, 2016 (Sessions 3 and 4), and available on demand through February 4, 2017
Posted by...Bernard Sklar, MD.
Free Diabetes CME Credit hours...1.0.
CME Credits Awarded by....Primary Care Network.
Instruction Type...Streaming Video Lecture and discussion.
Target Audiences...This program is intended for US-based primary care providers, clinical endocrinologists/diabetologists, nephrologists, cardiologists, emergency department specialists, pharmacists, and other clinicians caring for patients with type 2 diabetes.
Educational material updated...June 14, 2016.
Expiration of CME credit...February 4, 2017.
Financial Support...Novo Nordisk.
At the conclusion of the 4 sessions of The New Insulins are Coming, you will be able to:
Session 1:
• Identify T2DM patients who would benefit from insulin-based therapy
• Discuss strategies to overcome patient and clinician barriers to the successful initiation of insulin therapy
• Differentiate how new and emerging insulin products, including new entities and new modes of administration, differ from previously available insulin products with respect to pharmacokinetic and pharmacodynamic features 
Session 2:
• Apply key, clinically relevant data derived from pivotal trials of new and emerging insulin products
• Identify the potential place in therapy for new insulins, including how these indications compare to those of the previously available insulins
• Explain the similarities and differences between a follow-on (biosimilar) insulin and a reference insulin 
Session 3:
• Delineate methods for initiating and titrating new insulin products
• Explore the potential role for new insulins in helping patients meet diabetes management goals while minimizing adverse effects associated with insulin regimens 
Session 4:
• Apply learnings from previous activities to advance management of your patients using new insulin products
• Develop insulin regimens that are based on the product's pharmacodynamic properties and are tailored to the glycemic control needs of the patient